Scanogen, Inc.

Publicly observed

Baltimore, United States

Seen in a public record (e.g. a government grant database); not otherwise verified.

Details and provenance

Item	Value	Source	Status
Country	US	NIH RePORTER (opens in a new tab) 28 Sept 2026	Publicly observed
City / locality	Baltimore	NIH RePORTER (opens in a new tab) 28 Sept 2026	Publicly observed
Name	Scanogen, Inc.	NIH RePORTER (opens in a new tab) 28 Sept 2026	Publicly observed
UEI (U.S. federal entity ID)	JK9PMLM41J77	NIH RePORTER (opens in a new tab) 28 Sept 2026	Publicly observed

Grant17 Sept 2025Publicly observed
NIH SBIR/STTR award: Bloodstream infection detection directly on whole blood
USD 972,243.00 · National Institute of Allergy and Infectious Diseases · Source: NIH RePORTER (opens in a new tab)
Grant17 Sept 2025Publicly observed
NIH SBIR/STTR award: Bloodstream infection detection directly on whole blood
USD 969,449.00 · National Institute of Allergy and Infectious Diseases · Source: NIH RePORTER (opens in a new tab)
Grant17 Aug 2023Publicly observed
NIH SBIR/STTR award: Highly Multiplexed Single Molecule Tethering
USD 999,828.00 · National Institute of Allergy and Infectious Diseases · Source: NIH RePORTER (opens in a new tab)
Grant9 Jun 2023Publicly observed
NIH SBIR/STTR award: Culture and amplification-free bacterial sepsis diagnosis
USD 1,000,000.00 · National Institute of Allergy and Infectious Diseases · Source: NIH RePORTER (opens in a new tab)
Grant1 Jun 2016Publicly observed
NIH SBIR/STTR award: Bloodstream infection detection directly on whole blood
USD 1,000,000.00 · National Institute of Allergy and Infectious Diseases · Source: NIH RePORTER (opens in a new tab)
Grant1 Jun 2016Publicly observed
NIH SBIR/STTR award: Bloodstream infection detection directly on whole blood
USD 1,000,000.00 · National Institute of Allergy and Infectious Diseases · Source: NIH RePORTER (opens in a new tab)

Information only — not investment advice or an endorsement. Is this your company? Submit or update its details or request a correction.